The 1,2-diacylglycerol (DAG) mass content was measured in thrombin-stimulated human platelets. Thrombin stimulates a biphasic accumulation of DAG, with an early phase reaching a peak at 10 s and a later phase reaching a peak at 2-3 min. The time course of first-phase DAG production corresponded well to that of Ins(l,4,5)P3 formation, which was rapid and transient. The second phase of DAG accumulation occurred after the level of Ins(1,4,5)P3 returned to nearly basal. Thrombin stimulated the decrease in Ptdlns and phosphatidylcholine contents. The source of second-phase DAG was examined in platelets prelabelled with three radioactive fatty acids, i.e. arachidonic, palmitic and myristic. Thrombin stimulated the increase in radioactivity of DAG with decline of PtdIns in platelets labelled with [3H] [5, 6] . More recently, agonist-induced DAG formation from phosphatidylcholine (PtdCho) has also been demonstrated in many types of cells (see [7] ). PtdCho contains l-alkyl-2-acyl molecular species in addition to the diacyl form. The formation of l-alkyl-2-acyl-glycerol upon cell stimulation was also demonstrated in MDCK cells [8] and neutrophils [9] . It is suggested that the activation profiles of PKC isoenzymes would be different among the three types of diradylglycerols [10] [11] [12] .
INTRODUCTION
1,2-Diacylglycerol (DAG) functions as an intracellular second messenger which activates protein kinase C (PKC) [1] . Initially Ptdlns was considered to be the source of agonist-induced DAG formation [2] . However, in response to the agonist, hydrolysis of polyphosphoinositides has been shown to precede the decline in Ptdlns in many types of cells. On the basis of these observations, the decrease in Ptdlns upon cell stimulation was assumed to be the consequence of its consumption during the resynthesis of PtdInsP2 [3] . The concept is widely accepted that hydrolysis of PtdInsP2 by phospholipase C (PLC) upon stimulation of Ca2+-mobilizing receptors leads to the formation of DAG and Ins (1, 4, 5) P3 [4] . However, quantitative and temporal discrepancies between DAG and Ins(1,4,5)P3 formation in agoniststimulated cells have been demonstrated [5, 6] . More recently, agonist-induced DAG formation from phosphatidylcholine (PtdCho) has also been demonstrated in many types of cells (see [7] ). PtdCho contains l-alkyl-2-acyl molecular species in addition to the diacyl form. The formation of l-alkyl-2-acyl-glycerol upon cell stimulation was also demonstrated in MDCK cells [8] and neutrophils [9] . It is suggested that the activation profiles of PKC isoenzymes would be different among the three types of diradylglycerols [10] [11] [12] .
The formation of DAG has often been investigated in radiolabelled cells. However, in these studies the changes in DAG mass content could not be determined. A simple and sensitive method has been developed for measurement of DAG mass content by using Escherichia coli DAG kinase [13] . Several studies have demonstrated the biphasic accumulation of DAG in agonist-stimulated cells [14] [15] [16] [17] [18] [19] [20] [21] . In most cases, the first phase of DAG increase is rapid and transient, which is concurrent with Ins(1,4,5)P3 production. On the other hand, the second sustained DAG accumulation was reported to occur in the absence of Ins(1,4,5)P3 elevation, suggesting that DAG comes from other sources than PtdInsP2.
PKC plays an important role during stimulus-induced platelet responses. At least two types of PKC were reported to exist in platelets [22, 23] . The formation of DAG during agonist stimulation has been demonstrated. However, the details of DAG formation, e.g. phospholipid source(s) and pathway, are not fully understood in platelets. In the present study, the thrombininduced DAG accumulation was quantitatively analysed, and the possible phospholipid sources and pathway are discussed.
EXPERIMENTAL Preparation of platelets
Human platelets were obtained from healthy volunteers [24] , and isolated at room temperature. Platelet-rich plasma was obtained by centrifugation at 164 g for 10 min, and was then mixed with prostaglandin I2 (0.1 #g/ml) and potato apyrase (0.5 unit/ml) and gently layered on 40 % (w/v) BSA. Tubes were centrifuged for 15 min at 1000g. Plasma and BSA were carefully removed, and platelets were suspended in Tyrode-Hepes buffer (134 mM-NaCl, 12 mM-NaHCO3, 2.9 mM-KCI, 0.36 mmNaH2PO4, 1 mM-MgCl2, 5.6 mM-dextrose, 0.1 0% BSA, 10 [3H]Inositol-labelled platelets were finally suspended in TyrodeHepes buffer containing 10 mM-LiCl and left for 20 min before use. Platelet incubation and lipid extraction Platelets (1 x 109/250 ul) were equilibrated at 37°C for 5 min and then activated with thrombin. Just before incubation, 1 mmCa2+ or 1 mM-EGTA was added. At appropriate times, incubations were terminated by addition of 2 ml of chloroform/ methanol (1:2, v/v). For polyphosphoinositide analysis, the reaction was terminated by adding 2 ml of chloroform/ methanol/HCl (20:40: 1, by vol.). The lipids were extracted by the method of Bligh & Dyer [26] with slight modification [24] . The extracted lipids were analysed within 24 h. If necessary, the samples were dissolved in hexane/benzene (1:1, v/v) and were stored at -20°C to minimize acyl-group migration.
Assay of DAG mass content DAG mass content in crude lipid fractions was measured by the conversion of DAG into [32P]phosphatidic acid (PtdOH) by E. coli DAG kinase in the presence of [y-32P]ATP, by the method of Preiss et al. [13] . Incubations were carried out for 60 min at 30 'C. To quantify the content of alkylacyl-glycerol, 500 units of Rhizopus arrhizus lipase [27] , which possesses phospholipase A1 activity, was added after 60 min of incubation, and then incubation continued for an additional 60 min. Under these conditions, standard diacyl-PtdOH (from 1 nmol of DAG) was completely hydrolysed. After extraction, 32P-labelled lipids were separated on silica-gel 60 plates in the solvent system chloroform/methanol/acetic acid/water (30:15:4:2, by vol.). Radioactive spots were identified by autoradiography and were scraped into scintillation vials, to which 5 ml of scintillation cocktail was added. The radioactivity was counted in a Packard scintillation counter (Tricarb 4000). The amount of DAG present in the samples were calculated from the amount of [32P]PtdOH produced [13] .
Measurement of inositol phosphates
The aqueous phase of chloroform/methanol/HCl extract was neutralized with 1 M-Tris and diluted to 4 ml with water. Labelled inositol'phosphates were then separated by chromatography on a 1.0 ml Bio-Rad AG 1X8 anion-exchange column as described by Berridge et al. [28] . Individual fractions (4 ml) were mixed with Aquasol-2 and the radioactivity was counted. The mass of Ins(1,4,5)P3 was measured as described previously [29] .
Analysis of water-soluble choline metabolites
The aqueous phase of the chloroform/methanol extract was dried and resuspended in 50 % (v/v) ethanol. A portion of each sample was spotted on a Whatman LK6D plate, which was then developed with 0.5 % NaCl/methanol/conc. NH3 (50:50: 1, by vol.) [30] . Spots corresponding to choline, phosphocholine and glycerophosphocholine standards were scraped into vials and counted for radioactivity. Analysis of radiolabelied lipids Radiolabelled phospholipids were separated by twodimensional t.l.c. on silica-gel 60 plates impregnated with 2.5 % (w/v) magnesium acetate, by using chloroform/methanol/ 13.5 M-NH3 (65:35:6, by vol.) in the first direction, and chloroform/acetone/methanol/acetic acid/water (6:8:2:2: 1, by vol.) in the second direction [31] . Neutral lipids were separated on silica-gel 60 plates impregnated with 0.4 M-boric acid in the solvent system chloroform/acetone (24:1, v/v). For the separation of phosphoinositides, lipids were applied to a LK6D plate impregnated with 1 % potassium oxalate containing 2 mM-EDTA. Plate was developed in chloroform/methanol/4 M-NH3 (9:7:3, by vol.). Individual lipids were observed by exposure of the plates to iodine vapour and identified by co-migration with authentic standards. The areas corresponding to individual lipid fractions were scraped into vials, and radioactivity was determined in a liquid-scintillation counter as described above.
Measurement of phosphorus content of phospholipids
Phospholipids were separated by two-dimensional t.l.c. as described above. Fractionated phospholipids were digested with 70% (w/v) HC104 at 180°C for 30 min, and inorganic phosphorus content was determined [32, 33] . 
Materials

RESULTS
DAG formation
Platelets were stimulated with 1 unit of thrombin/ml for the indicated periods of time. After lipid extraction, the DAG mass contents were determined. Control resting platelets contain 98 + 36 pmol of DAG/109 cells (n = 8). Stimulation with thrombin induced a biphasic accumulation of DAG, as shown in Fig.  1 . The early phase showed a sharp rapid peak at 10 s after stimulation. On the other hand, the second-phase DAG generation is rather slow and sustained, reaching a maximum at 2 min. When extracellular Ca2+ was chelated by EGTA, the thrombin-induced increase in DAG was monophasic, reached its peak at 10 s and returned to the control level by 1 min. The second phase, observed in the presence of extracellular Ca2+, disappeared.
Recently the accumulation of alkylacylglycerol from alkylacylPtdCho has been demonstrated, when human neutrophils were stimulated with N-formylmethionyl-leucyl-phenylalanine [9, 27] .
Platelets also contain alkylacyl-PtdCho, which is about 10 % of total diradyl-PtdCho [34] . Next, the formation of alkylacylglycerol was investigated in thrombin-stimulated platelets. E. coli DAG kinase converts alkylacylglycerol to alkylacyl-[32P]PtdOH.
However, the latter could not be resolved on the t. . 30 s, and maintained their levels for 3-5 min (results not shown). Similar trends have previously been reported [36, 37] . However, the InsP3 accumulated after 30 s appeared to be Ins(1,3,4)P3, and Ins(l,4,5)P3 was not detectable [38] , in accordance with (Fig.  6 ). The increase in radioactivity was found in lyso-PtdCho and glycerophosphocholine fractions ( 
Phosphatidylethanol (PtdEtOH) formation
The agonist-induced DAG formation from PtdCho via the phospholipase D (PLD)/PtdOH phosphohydrolase pathway has been reported in human neutrophils [9] . In the presence of ethanol, activation of PLD results in the formation of PtdEtOH, owing to a PLD-catalysed transphosphatidylation [39] . The thrombin-induced accumulation of PtdEtOH in platelets has previously been reported by Rubin [40] . (Table 3) . However, at 2 min after throm- - 
DISCUSSION
The present results indicate that thrombin induces a biphasic accumulation of DAG in human platelets, which has previously been reported in many types of cells [14] [15] [16] [17] [18] [19] [20] [21] . The first DAG peak was rapid and transient after stimulation. The time course of the first DAG peak well corresponded to that of a transient Ins(1,4,5)P3 accumulation ( Figs. 1 and 2) . The coincident formation of Ins(1,4,5)P3 and DAG suggest that the DAG source is Ptd1nsP2. The content of PtdInsP2 has been shown to be about 1 nmol/109 platelets [41, 42] . By mass analysis Broekman [41] demonstrated that 30-40% of PtdInsP2 was hydrolysed within 10 s upon thrombin stimulation. Stimulation with thrombin produced an increase of approx. 300 pmol of DAG/109 platelets at 10 s (Fig. 1) , which could be explained by hydrolysis of 30 % of the PtdInsP2. However, the net increase in the first phase of DAG exceeds that of InsP3, as often observed in other types of cells [20, 21] It has recently been proposed that DAG was mainly derived from the PtdCho-PLD/PtdOH phosphohydrolase pathway in N-formylmethionyl-leucyl-phenylalanine-stimulated human neutrophils [9] . In the presence of ethanol PLD catalyses a transphosphatidylation reaction to form PtdEtOH. The formation of PtdEtOH is a sensitive and useful indicator of PLD activity [39] . However, stimulatory or inhibitory effects of ethanol on platelet phospholipid turnover have been demonstrated. Rand et al. [54] have shown that ethanol has inhibitory effects on platelet functions induced by very low concentrations (<0.01 unit/ml) of thrombin by attenuating the production of InsP3. [40] . However, the increase in PtdEtOH was much less compared with PtdOH production. These results suggest that PLD plays a minor role, if any, in platelets. Accordingly, Randall et al. [56] reported that the PLD activity of human platelets is one-fiftieth of that of human neutrophils. Accumulating evidence has suggested that the biphasic DAG formation, especially the second sustained phase, is closely coupled with mitogenic signal transduction [16, 57, 58] . We have shown here that thrombin stimulates a biphasic DAG accumulation in the platelet, anucleated and non-mitogenic cell. The first phase of DAG accumulation and Ins(1,4,5)P, production was independent of extracellular Ca2+. 5 However, all experiments showed consistent results. Based on the combined weight of the present data, the above proposal seems to be reasonable. Further studies are necessary to clarify the physiological significance and the regulatory mechanism of DAG formation in platelets.
